Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system
Authors:
- 13 January 2015
- journal article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 18 (2) , 104-109
Abstract
African-American men with prostate cancer typically have higher tumor risk at diagnosis, lower rates of surgical treatment and poorer cancer-specific survival compared with Caucasians. Receipt of care within the Veterans Affairs (VA) healthcare system may reduce barriers that influence these disparities. We sampled 1258 men with nonmetastatic prostate cancer diagnosed at the Greater Los Angeles and Long Beach VA Medical Centers between 1998 and 2004. We compared African Americans and Caucasians with respect to tumor characteristics using ordinal logistic regression, treatment choice across substrata of tumor risk using logistic regression, and cancer-specific and other-cause mortality using competing risks regression analysis. Multivariate ordinal logistic regression revealed no significant differences in odds of higher tumor risk (odds ratio (OR) 1.22, 95% confidence interval (CI) 0.98-1.53, P=0.08), Gleason score (OR 0.90, 95% CI 0.7-1.16, P=0.4) or clinical stage (OR 1.04, 95% CI 0.79-1.38, P=0.8) for African Americans compared with Caucasians. African-American men had similar odds of aggressive treatment as did Caucasians for low-risk (OR 0.92, 95% CI 0.57-1.53, P=0.8), intermediate-risk (OR 0.75, 95% CI 0.44-1.26, P=0.3) and high-risk disease (OR 0.87, 95% CI 0.52-1.44, P=0.6). In competing risks regression analysis, African Americans had a lower but nonsignificant hazard of cancer-specific mortality compared with Caucasians (sub-hazard ratio 0.6, 95% CI 0.28-1.26, P=0.2) and nearly identical risk of other-cause mortality (sub-hazard ratio 0.98, 95% CI 0.78-1.22, P=0.8). We found no significant differences in tumor burden, treatment choice or survival outcomes between African Americans and Caucasians cared for in the equal-access VA Healthcare setting.Keywords
This publication has 25 references indexed in Scilit:
- Impact of Ethnicity on Primary Treatment Choice and Mortality in Men With Prostate Cancer: Data From CaPSUREJournal of Clinical Oncology, 2010
- Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical ProstatectomyJournal of Urology, 2008
- Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomyCancer, 2007
- Differences in Prognostic Factors and Survival among White Men and Black Men with Prostate Cancer, California, 1995-2004American Journal of Epidemiology, 2007
- Racial treatment trends in localized/regional prostate carcinoma: 1992–1999Cancer, 2005
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system1995
- Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men1995
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987